Cargando…

RanBPM Is an Inhibitor of ERK Signaling

Ran-binding protein M (RanBPM) is a nucleocytoplasmic protein of yet unknown function. We have previously shown that RanBPM inhibits expression of the anti-apoptotic factor Bcl-2 and promotes apoptosis induced by DNA damage. Here we show that the effects of RanBPM on Bcl-2 expression occur through a...

Descripción completa

Detalles Bibliográficos
Autores principales: Atabakhsh, Elnaz, Schild-Poulter, Caroline
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3485245/
https://www.ncbi.nlm.nih.gov/pubmed/23118896
http://dx.doi.org/10.1371/journal.pone.0047803
_version_ 1782248266361995264
author Atabakhsh, Elnaz
Schild-Poulter, Caroline
author_facet Atabakhsh, Elnaz
Schild-Poulter, Caroline
author_sort Atabakhsh, Elnaz
collection PubMed
description Ran-binding protein M (RanBPM) is a nucleocytoplasmic protein of yet unknown function. We have previously shown that RanBPM inhibits expression of the anti-apoptotic factor Bcl-2 and promotes apoptosis induced by DNA damage. Here we show that the effects of RanBPM on Bcl-2 expression occur through a regulation of the ERK signaling pathway. Transient and stable down-regulation of RanBPM stimulated ERK phosphorylation, leading to Bcl-2 up-regulation, while re-expression of RanBPM reversed these effects. RanBPM was found to inhibit MEK and ERK activation induced by ectopic expression of active RasV12. Activation of ERK by active c-Raf was also prevented by RanBPM. Expression of RanBPM correlated with a marked decrease in the protein levels of ectopically expressed active c-Raf and also affected the expression of endogenous c-Raf. RanBPM formed a complex with both active c-Raf, consisting of the C-terminal kinase domain, and endogenous c-Raf in mammalian cells. In addition, RanBPM was found to decrease the binding of Hsp90 to c-Raf. Finally, we show that loss of RanBPM expression confers increased cell proliferation and cell migration properties to HEK293 cells. Altogether, these findings establish RanBPM as a novel inhibitor of the ERK pathway through an interaction with the c-Raf complex and a regulation of c-Raf stability, and provide evidence that RanBPM loss of expression results in constitutive activation of the ERK pathway and promotes cellular events leading to cellular transformation and tumorigenesis.
format Online
Article
Text
id pubmed-3485245
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-34852452012-11-01 RanBPM Is an Inhibitor of ERK Signaling Atabakhsh, Elnaz Schild-Poulter, Caroline PLoS One Research Article Ran-binding protein M (RanBPM) is a nucleocytoplasmic protein of yet unknown function. We have previously shown that RanBPM inhibits expression of the anti-apoptotic factor Bcl-2 and promotes apoptosis induced by DNA damage. Here we show that the effects of RanBPM on Bcl-2 expression occur through a regulation of the ERK signaling pathway. Transient and stable down-regulation of RanBPM stimulated ERK phosphorylation, leading to Bcl-2 up-regulation, while re-expression of RanBPM reversed these effects. RanBPM was found to inhibit MEK and ERK activation induced by ectopic expression of active RasV12. Activation of ERK by active c-Raf was also prevented by RanBPM. Expression of RanBPM correlated with a marked decrease in the protein levels of ectopically expressed active c-Raf and also affected the expression of endogenous c-Raf. RanBPM formed a complex with both active c-Raf, consisting of the C-terminal kinase domain, and endogenous c-Raf in mammalian cells. In addition, RanBPM was found to decrease the binding of Hsp90 to c-Raf. Finally, we show that loss of RanBPM expression confers increased cell proliferation and cell migration properties to HEK293 cells. Altogether, these findings establish RanBPM as a novel inhibitor of the ERK pathway through an interaction with the c-Raf complex and a regulation of c-Raf stability, and provide evidence that RanBPM loss of expression results in constitutive activation of the ERK pathway and promotes cellular events leading to cellular transformation and tumorigenesis. Public Library of Science 2012-10-31 /pmc/articles/PMC3485245/ /pubmed/23118896 http://dx.doi.org/10.1371/journal.pone.0047803 Text en © 2012 Atabakhsh, Schild-Poulter http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Atabakhsh, Elnaz
Schild-Poulter, Caroline
RanBPM Is an Inhibitor of ERK Signaling
title RanBPM Is an Inhibitor of ERK Signaling
title_full RanBPM Is an Inhibitor of ERK Signaling
title_fullStr RanBPM Is an Inhibitor of ERK Signaling
title_full_unstemmed RanBPM Is an Inhibitor of ERK Signaling
title_short RanBPM Is an Inhibitor of ERK Signaling
title_sort ranbpm is an inhibitor of erk signaling
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3485245/
https://www.ncbi.nlm.nih.gov/pubmed/23118896
http://dx.doi.org/10.1371/journal.pone.0047803
work_keys_str_mv AT atabakhshelnaz ranbpmisaninhibitoroferksignaling
AT schildpoultercaroline ranbpmisaninhibitoroferksignaling